Literature DB >> 21133611

Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand.

Petcharin Srivatanakul1, Satoshi Honjo, Pacharin Kittiwatanachot, Adisorn Jedpiyawongse, Thiravud Khuhaprema, Masanao Miwa.   

Abstract

Liver cancer is the most common cancer in males in Thailand and the third in females. A high incidence of cholangiocarcinoma (CCA) is estimated in the northeast of Thailand. Chronic infection with Opisthorchis viverrini (OV) is the major risk factor for development of CCA. It has been demonstrated that HCV infection is a risk factor for CCA in non - endemic area of OV infection. We examined the association of HBV and HCV and risk of CCA in the northeast Thailand. All cases of CCA were recruited between 1999 and 2001 from Nakhon Phanom provincial hospital and all community hospitals in the province. One control per case was selected, matched by sex, age (∓5 years) and residence. 106 case-control pairs were obtained. Anti-OV, HBsAg, and Anti HCV were determined by ELISA. Among 103 age-sex-place of residence matched case-control pairs, there were 7, 0, 0, 96 pairs for anti-HCV (+) case vs. (-) control, (+) case vs. (+) control, (-) case vs. (+) control and (-) case vs. (-) control combinations (OR=7/0). Among 106 matched pairs, there were 9, 2, 4, 91 pairs for the similar four combinations of HBsAg (OR=2.25 (95%CI: 0.63-10.0). If the subject had anti-HCV and/or HBsAg, the OR for CCA was 4.00 (95%CI: 1.29-16.4). Even after adjustment for anti-OV, risk for HBsAg and/or anti-HCV positive was still marginally increased with an OR of 4.69 although not reaching statistical significance (95%CI: 0.98-22.5). Hepatitis B and C virus infection may also play role in the development of CCA in northeast Thailand.

Entities:  

Mesh:

Year:  2010        PMID: 21133611

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  11 in total

Review 1.  Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand.

Authors:  Masanao Miwa; Satoshi Honjo; Gyokukou You; Masakazu Tanaka; Kazuhiko Uchida; Petcharin Srivatanakul; Thiravud Khuhaprema; Watcharin Loilome; Anchalee Techasen; Chaisiri Wongkham; Temduang Limpaiboon; Puangrat Yongvanit; Sopit Wongkham
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

2.  Viral hepatitis B and C infections increase the risks of intrahepatic and extrahepatic cholangiocarcinoma: Evidence from a systematic review and meta-analysis.

Authors:  Jie-Hui Tan; Wan-Yan Zhou; Lei Zhou; Rong-Chang Cao; Guo-Wei Zhang
Journal:  Turk J Gastroenterol       Date:  2020-03       Impact factor: 1.852

Review 3.  Possible association between hepatitis C virus and malignancies different from hepatocellular carcinoma: A systematic review.

Authors:  Sirio Fiorino; Letizia Bacchi-Reggiani; Dario de Biase; Adele Fornelli; Michele Masetti; Andrea Tura; Fabio Grizzi; Matteo Zanello; Laura Mastrangelo; Raffaele Lombardi; Giorgia Acquaviva; Luca di Tommaso; Arrigo Bondi; Michela Visani; Sergio Sabbatani; Laura Pontoriero; Carlo Fabbri; Andrea Cuppini; Annalisa Pession; Elio Jovine
Journal:  World J Gastroenterol       Date:  2015-12-07       Impact factor: 5.742

Review 4.  Hepatitis C virus infection and the risk of intrahepatic cholangiocarcinoma and extrahepatic cholangiocarcinoma: evidence from a systematic review and meta-analysis of 16 case-control studies.

Authors:  Hao Li; Bin Hu; Zun-Qiang Zhou; Jiao Guan; Zheng-Yun Zhang; Guang-Wen Zhou
Journal:  World J Surg Oncol       Date:  2015-04-23       Impact factor: 2.754

Review 5.  HBV Infection Status and the Risk of Cholangiocarcinoma in Asia: A Meta-Analysis.

Authors:  Hao Zhang; Biqing Zhu; He Zhang; Jianxin Liang; Wenting Zeng
Journal:  Biomed Res Int       Date:  2016-11-23       Impact factor: 3.411

6.  Characteristics and outcomes of cholangiocarcinoma by region in Thailand: A nationwide study.

Authors:  Roongruedee Chaiteerakij; Wirichada Pan-Ngum; Kittiyod Poovorawan; Ngamphol Soonthornworasiri; Sombat Treeprasertsuk; Kamthorn Phaosawasdi
Journal:  World J Gastroenterol       Date:  2017-10-21       Impact factor: 5.742

Review 7.  Thinking beyond Opisthorchis viverrini for risk of cholangiocarcinoma in the lower Mekong region: a systematic review and meta-analysis.

Authors:  Jennifer A Steele; Carsten H Richter; Pierre Echaubard; Parichat Saenna; Virginia Stout; Paiboon Sithithaworn; Bruce A Wilcox
Journal:  Infect Dis Poverty       Date:  2018-05-17       Impact factor: 4.520

Review 8.  Risk Factors for Cholangiocarcinoma in Thailand: A Systematiczzm321990Review and Meta-Analysis

Authors:  Siriporn Kamsa-ard; Supot Kamsa-ard; Vor Luvira; Krittika Suwanrungruang; Patravoot Vatanasapt; Surapon Wiangnon
Journal:  Asian Pac J Cancer Prev       Date:  2018-03-27

Review 9.  The Curious Case of Cholangiocarcinoma: Opportunities for Environmental Health Scientists to Learn about a Complex Disease.

Authors:  William A Suk; Vajarabhongsa Bhudhisawasdi; Mathuros Ruchirawat
Journal:  J Environ Public Health       Date:  2018-08-09

10.  Osteopontin and latent-TGF β binding-protein 2 as potential diagnostic markers for HBV-related hepatocellular carcinoma.

Authors:  Andre Nogueira da Costa; Amelie Plymoth; Daniela Santos-Silva; Sandra Ortiz-Cuaran; Suzy Camey; Paule Guilloreau; Suleeporn Sangrajrang; Thiravud Khuhaprema; Maimuna Mendy; Olufunmilayo A Lesi; Hee-Kyung Chang; Jin-Kyoung Oh; Duk-Hee Lee; Hai-Rim Shin; Gregory D Kirk; Philippe Merle; Laura Beretta; Pierre Hainaut
Journal:  Int J Cancer       Date:  2014-05-15       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.